FlowCardia Expands Options for Patients With Chronic Total Occlusions


October 22, 2009

October 22, 2009 – FlowCardia Inc. yesterday began its U.S. launch of the over the wire (OTW) delivery platform for the CROSSER 14S and CROSSER 14P peripheral chronic total occlusions (CTOs) recanalization catheters.

The Over the Wire CROSSER Catheter delivery platform provides interventional cardiologists, vascular surgeons, and interventional radiologists with an endovascular tool to treat even the most distal and complex peripheral occlusions. CROSSER OTW catheters facilitate guide wire exchanges using peripheral interventionalists' preferred delivery platform, thus providing various levels of catheter support, pushability, and steerability during percutaneous treatment in patients suffering from blocked arteries in the legs.

"The new Over the Wire CROSSER Catheter allows me to freely exchange my guide wire, giving me the steerability and support necessary to tackle the toughest of CTOs with ease," said David Allie, M.D., a cardiothoracic surgeon at the Medical Center of Acadiana in Lafayette, La. "When faced with CTOs, I use CROSSER as my frontline therapy to stay in the central lumen, giving me the freedom to choose the best subsequent treatment option for patients suffering from completely blocked arteries."

The CROSSER Catheter is a minimally-invasive endovascular device that utilizes high-frequency, mechanical vibration to facilitate passage through blockages in the peripheral and coronary arteries. It is designed as a frontline therapy to enable central lumen crossing of chronically occluded arteries thereby maximizing physicians' therapeutic options. More than 7,500 CROSSER Catheter procedures have been performed to date by physicians around the world.

For more information: www.flowcardia.com